Commitments received for further $550k via placement
Filed with ASX · · 1 page · English
Summary by 6ix AI
The placement involves issuing new shares at the same price as the entitlement offer, with additional options attached to the shares. Proceeds from the placement will enhance the company's ability to pursue new asset opportunities and cover offer costs. Shareholder approval will be sought for the placement and associated options at an upcoming general meeting.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Cynata Therapeutics Limited on 6ix
Earlier from Cynata Therapeutics
- Results of Fully Underwritten Entitlement Offer
- September 2026 Quarterly Activity Report & Appendix 4C
- Prospectus
- Entitlement Offer & Unmarketable Parcel Sale Facility
- Termination of At-the-Market Subscription Deed
Later from Cynata Therapeutics
All Cynata Therapeutics news releasesFollow Cynata Therapeutics into a list and get an email when it puts out news.
Follow Cynata Therapeutics